LEXINGTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric
patients, today announced CEO Fred Chereau will present at the Chardan Virtual Genetic Medicines Conference on Monday, October 5, 2020 at 11 AM, ET.

A live audio webcast of the presentation will be

Post Views: 179

PREVIOUS ARTICLE

OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial

NEXT ARTICLE

LogicBio Therapeutics to Present at the Jefferies Virtual Gene Editing/Therapy Summit October 2, 2020

Related Post

Dax aktuell: Zinssorgen bestätigt: Dax dreht trotz guter Konjunkturdaten ins Minus

Dax aktuell: Zinssorgen bestätigt: Dax dreht trotz guter Konjunkturdaten ins Minus
/ Feb 21
Verimatrix-Sicherheitsexperte für Video-Content spricht auf dem SportsPro Asia Virtual Summit

Verimatrix-Sicherheitsexperte für Video-Content spricht auf dem SportsPro Asia Virtual Summit
/ Okt 21
Wall Street: Firmenbilanzen stützen Wall Street – Zinssorgen bleiben

Wall Street: Firmenbilanzen stützen Wall Street – Zinssorgen bleiben
/ Jan 19